ReShape Lifesciences Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ReShape Lifesciences Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • ReShape Lifesciences Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $177K, a 35.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $177K -$97K -35.4% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $202K -$95K -32% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $226K +$140K +163% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $250K +$79K +46.2% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $274K +$19K +7.45% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $297K -$41K -12.1% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $86K -$438K -83.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $171K -$95K -35.7% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $255K -$195K -43.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $338K -$294K -46.5% Jun 30, 2022 10-Q 2022-08-19
Q1 2022 $524K +$103K +24.5% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 $266K -$199K -42.8% Dec 31, 2021 10-K 2023-04-17
Q3 2021 $450K -$196K -30.3% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $632K -$116K -15.5% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $421K -$1.08M -71.9% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $465K -$612K -56.8% Dec 31, 2020 10-K 2022-04-08
Q3 2020 $646K Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $748K Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $1.5M Mar 31, 2020 10-Q 2020-06-19
Q4 2019 $1.08M Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.